Health Conditions

Bronchitis

Other NamesAcute and subacute bronchitis with bronchospasm

Natural Remedies10

Ingredients160

Table of contents

Other Names

Acute and subacute bronchitis with bronchospasmAcute and subacute bronchitis with tracheitisAcute bacterial bronchitisAcute bronchitisAcute bronchitis, unspecifiedAcute fibrinous bronchitisAcute membranous bronchitisAcute purulent bronchitisAcute septic bronchitisAcute tracheobronchitisAcute viral bronchitisBronchial catarrhBronchial inflammationBronchial irritationBronchitis NOSBronchitis, ChronicChest coldChronic bronchitisChronic mucopurulent bronchitisChronic obstructive bronchitisDiffuse bronchitisFibrinous bronchitisHypostatic bronchitisInfective bronchitisInflammation of the bronchiLower respiratory tract infection (bronchial)Membranous bronchitisObstructive bronchitisProtracted bacterial bronchitisPurulent bronchitisSimple chronic bronchitisSmoker's coughSubacute bronchitisTracheobronchitis

Synopsis

Bronchitis: A Nutrition and Natural Health Reference

1. Definition and Overview

Bronchitis is an inflammatory condition of the bronchial tubes, the air passages that carry air to and from the lungs. It typically involves the inflammation of the mucous membranes lining the bronchial tubes, leading to increased production of mucus; this inflammation narrows the airways, causing coughing, wheezing, and difficulty breathing. The condition is conventionally divided into two clinically and pathophysiologically distinct forms: acute bronchitis and chronic bronchitis.

Acute Bronchitis

Acute bronchitis can be defined as an infectious, generally viral, respiratory illness that lasts for 1–3 weeks and occurs in an otherwise healthy adult, with cough as the predominant feature. In addition to cough and usually sputum production, acute bronchitis frequently involves upper respiratory symptoms and constitutional complaints such as fatigue and body aches; an illness comprised of these symptoms may be classified as acute bronchitis once the diagnosis of pneumonia is excluded. Acute bronchitis manifests as an inflammation of these bronchi without evidence of pneumonia and typically affects individuals without underlying chronic obstructive pulmonary disease (COPD). As a self-limiting condition, it typically follows a benign course, resolving spontaneously over 1 to 3 weeks.

Chronic Bronchitis

As a form of chronic obstructive pulmonary disease (COPD), chronic bronchitis is characterized by irreversible or incompletely reversible airway obstruction that produces a decrease in maximal expiratory airflow. Clinically, chronic bronchitis is defined by persistent productive cough lasting at least three months per year for two consecutive years, in the absence of other explanatory causes.

2. Body Systems Involved and Pathophysiology

Primary System: Respiratory

Acute bronchitis is inflammation affecting the large and mid-sized airways (bronchi); the condition involves the lower respiratory tract, specifically targeting the bronchi, the prominent air passages responsible for air transport within the lungs. Bronchitis is the inflammatory response of the bronchial epithelium to infections or irritants; the pathophysiological findings seen with acute bronchitis include wall thickening, inflammation, and increased mucus production. Physiologically, bronchitis disrupts the normal flow of air into the lungs, impeding oxygen exchange and causing respiratory distress.

Cellular and Immunological Mechanisms in Chronic Bronchitis

Chronic bronchitis involves both innate and adaptive immune responses; predominance of neutrophils and peribronchial distribution of fibrotic changes result from the action of interleukin (IL)-8, colony-stimulating factors (CSFs), and other chemotactic and proinflammatory cytokines. Immune cells, such as macrophages and T lymphocytes, release inflammatory mediators; these mediators, like cytokines and chemokines, cause inflammation and damage airways; chronic inflammation causes airway remodeling.

Constant irritants lead to hypertrophy (enlargement) of the mucus-secreting glands of the bronchial tree, an increase in the number of goblet cells resulting in increased mucus secretion; the smooth muscle in the airways becomes thicker and narrows the bronchioles. The cilia become unable to cope with excessive secretions, and therefore the mucus blocks the airways; the mucus goes deeper into the lungs and becomes harder to clear. Mucociliary dysfunction is a key part of chronic bronchitis.

Chronic bronchitis also makes the airway walls thicker because of fibrosis; this thickening is due to inflammation and the buildup of collagen, which narrows the airway, making breathing harder.

3. Contributing and Associated Factors

Infection

The primary pathological process involves irritation or infection of the bronchial tubes, often triggered by viruses or bacteria. The most common cause of acute bronchitis is a viral infection; responsible viruses include the influenza virus, rhinovirus (often associated with the common cold), and certain strains of coronavirus. In instances where the infection is of bacterial origin, the isolated pathogens tend to overlap with those commonly associated with community-acquired pneumonia.

Tobacco Smoke

Smoking is the single most significant risk factor for the development of chronic bronchitis and a major aggravator of acute bronchitis. Smoking impairs ciliary movement, inhibits the function of alveolar macrophages, and leads to hypertrophy and hyperplasia of mucus-secreting glands; it can also increase airway resistance via vagally mediated smooth-muscle constriction. Smoking has been estimated to account for 85–90% of cases of chronic bronchitis and COPD; studies have indicated that smoking pipes, cigars, and marijuana causes similar damage.

Environmental Exposures

Several risk factors contribute to the development of acute bronchitis, including a history of smoking, residence in polluted areas, crowded living conditions, and a prior history of asthma; specific allergens such as pollen, perfume, and vapors can potentially trigger acute bronchitis in susceptible individuals. Exposure to other inhaled irritants such as second-hand smoke, fumes, or pollutants can also contribute to the development of chronic bronchitis. Exposure to mold or dampness in the home has been linked to an increased risk of bronchitis; mold spores can trigger respiratory symptoms and worsen existing lung conditions.

Occupational and Genetic Factors

Frequent childhood respiratory infections, poor air quality in cities, exposure to certain chemicals or dusts at work, and family history of bronchitis also play a role in increasing the risk. Genetic factors can also play a role in some cases, where individuals who have never smoked or been exposed to workplace pollution may still develop chronic bronchitis due to their genetic makeup.

Age and Early-Life Factors

A study in the United Kingdom reported an incidence of 54 cases of acute bronchitis per 1,000 persons, with lower rates among younger men (36 per 1,000) and higher rates in individuals older than 85 (225 per 1,000). A long-term prospective study found that children who had bronchitis at least once before the age of 7 years were more likely to have been diagnosed with asthma and pneumonia by age 53 years; the association was strongest for participants with a history of recurrent or protracted childhood bronchitis.

4. Nutrients Studied in Relation to Bronchitis and Respiratory Infections

The following section addresses nutrients investigated in the context of acute respiratory infections broadly (including bronchitis) and chronic bronchitis/COPD. Evidence quality is characterized where possible.

Vitamin C (Ascorbic Acid)

Scientific Evidence: Vitamin C supplementation has been shown to reduce the risk of acute respiratory infections (ARIs) (RR=0.96; 95% CI 0.93 to 0.99; p=0.01) and to shorten the duration of symptoms (per cent difference: −9%; 95% CI −16% to −2%; p=0.014). The effect of vitamin C on preventing ARI was stronger among men and in middle-income countries, compared with women and high-income countries, respectively. These findings derive from a systematic review and meta-analysis of randomized controlled trials (RCTs). The research indicates that vitamin C may have a mitigating effect on viral respiratory infections.

Non-enzymatic antioxidants including vitamins C and E, carotene, and glutathione are present at lower levels in smokers than in non-smokers; vitamin C has a synergistic effect with vitamin E on antioxidant activity, and elevated serum levels of vitamin E show protection against COPD mortality. The evidence in COPD/chronic bronchitis is largely observational; interventional evidence for vitamin C specifically in chronic bronchitis populations remains limited.

Vitamin D (Cholecalciferol)

Scientific Evidence: Experimental evidence and observations in large cohorts are generally consistent that vitamin D deficiency (<50 nmol/L) and insufficiency (<75 nmol/L) of serum 25-hydroxycholecalciferol is associated with increased risk of acute respiratory tract infections (ARTI), and supplementation for those with deficiency/insufficiency may lead to clinically meaningful reductions in incidence of ARTI. However, current experimental evidence remains inconclusive regarding the effects of vitamin D supplementation in the general population for the prevention and treatment of ARTI; there is also insufficient evidence to draw conclusions regarding the impact of vitamin D supplementation on the severity or duration of ARTI, nor on outcomes related to lung injury or hospitalization from ARTI.

Significant differences in 25(OH)D levels were identified between a control group and children with bronchopneumonia, acute bronchitis, and laryngotracheitis (p < 0.01, p < 0.05). Vitamin D plays a key role in the activation of the innate immune system, particularly during lower respiratory tract infections; it increases mucociliary clearance, regulates epithelial cell production, and modulates inflammatory pathways.

Zinc

Scientific Evidence: Zinc supplementation did not reduce the risk of ARIs but shortened the duration of symptoms substantially (per cent difference: −47%; 95% CI −73% to −21%; p=0.0004). Zinc supplementation and probiotics emerge as potential preventive measures for both viral respiratory infections, with selenium and magnesium also warranting attention. This evidence is drawn from meta-analyses of RCTs, though the quality of individual trials varies and findings should be interpreted with appropriate caution.

Vitamin E (Tocopherols)

Scientific Evidence: After an analysis of NHANES III data, lower serum levels of alpha-tocopherol were associated with an increase in exacerbations and chronic bronchitis/emphysema, although the effect of alpha-tocopherol was observed and described as anti-inflammatory primarily in smokers. This association is observational, and interventional data are limited. Understanding the roles of vitamins A, B, and E is hampered by limited data availability.

Carotenoids (including Beta-Carotene)

Scientific Evidence: Evidence suggests that carotenoids, vitamin D, and vitamin E help protect against pollution damage which can trigger asthma, COPD, and lung cancer initiation. The development of chronic respiratory diseases is influenced by environmental exposures such as air pollution, smoking, occupational hazards, and genetic predispositions; a composite dietary antioxidant index (CDAI) is negatively associated with the prevalence of chronic respiratory diseases (especially emphysema and chronic bronchitis) in the adult population, highlighting a potential benefit to diets high in antioxidant-rich foods with regard to lung function.

Omega-3 Fatty Acids

Scientific Evidence: An increasing amount of evidence supports the notion that vitamins C, D, and E, carotenoids, and omega-3 fatty acids may protect against the progression of chronic respiratory diseases. Alpha-linolenic acid (ALA) and its long-chain derivatives eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are polyunsaturated fatty acids (PUFA) of the n-3 (omega-3) family; due to the low efficiency of endogenous synthesis, they are considered nutritionally essential and depend on exogenous sources, mainly seafood (fatty fish). The evidence for omega-3 in chronic bronchitis specifically is largely from observational and review data; large interventional trials focused on bronchitis are lacking.

Probiotics

Scientific Evidence: Probiotics emerge as potential preventive measures for both COVID-19 and viral respiratory infections. A synthesis of global evidence from RCTs indicates that micronutrient supplements including zinc, vitamins C and D, and multiple micronutrient supplements may be modestly effective in preventing ARIs and improving their clinical course. Evidence specifically linking probiotics to bronchitis outcomes is limited; most data comes from broader acute respiratory infection trials.

5. Herbs and Natural Ingredients: Traditional Use and Scientific Evidence

Pelargonium sidoides (South African Geranium / Umckaloabo)

Traditional Use: Pelargonium sidoides, a traditional medicinal plant native to South Africa, has been used medicinally for centuries; its roots have a long history of use in traditional Southern African medicine for respiratory conditions.

Scientific Evidence: Pelargonium sidoides acts through antiviral, indirect antibacterial, immunomodulatory, and expectorant effects. In a randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of EPs 7630 in 468 adults with acute bronchitis present for ≤48 hours, 30 drops three times daily for 7 days resulted in a decrease of the Bronchitis Severity Score (BSS) from baseline to day 7 of 5.9 ± 2.9 points under EPs 7630 compared with 3.2 ± 4.1 points under placebo. All RCTs in a systematic review and meta-analysis reported findings suggesting the effectiveness of P. sidoides in treating acute bronchitis; meta-analysis of four placebo-controlled RCTs suggested that EPs 7630 significantly reduced bronchitis symptom scores in patients with acute bronchitis by day 7; no serious adverse events were reported; and the authors concluded there is encouraging evidence that P. sidoides is effective compared to placebo for patients with acute bronchitis.

Eight RCTs investigating the application of EPs 7630 in acute bronchitis, acute tonsillopharyngitis, and acute respiratory tract infections (aRTI) in the context of chronic preconditions were identified in a review of children; results showed a statistically significant improvement of aRTI symptom severity for EPs 7630 as compared to controls. The European Respiratory Society has acknowledged P. sidoides root extract as a natural remedy available for the treatment of the symptoms of acute bronchitis. Evidence quality is characterized as moderate; a Cochrane review (Timmer et al., 2013, CD006323) covers this literature base, noting the need for further well-controlled trials.

Ivy Leaf (Hedera helix)

Traditional Use: Ivy leaf preparations have been used for centuries in European folk medicine as expectorants and cough remedies; historically, the herb was prepared as infusions and syrups for bronchial complaints and catarrh.

Scientific Evidence: Only one RCT (n=360) investigating an ivy/thyme combination used a placebo control and showed statistically significant superiority in reducing the frequency and duration of cough; all other studies lack a placebo control and show serious methodological flaws. Although all studies report that ivy extracts are effective to reduce symptoms of upper respiratory tract infections, there is no convincing evidence due to serious methodological flaws and lack of placebo controls. A multi-center, randomized, open-label clinical trial revealed that ivy extract EA 575 is non-inferior in acute bronchitis treatment compared to combination herbal comparators. Only one double-blind, active-controlled randomized study was retrieved as evidence for the possible efficacy and safety of ivy leaf dry extract in acute lower respiratory tract infections (level of evidence IIC); insufficient evidence was found that ivy leaf dry extracts might effectively improve acute upper respiratory tract infection symptoms in children. Overall, the evidence for ivy leaf monotherapy is preliminary and methodologically weak; combination preparations (ivy plus thyme) have somewhat stronger, though still limited, support.

Thyme (Thymus vulgaris)

Traditional Use: Thyme has been used medicinally for thousands of years; beyond its common culinary application, it has been recommended for a myriad of indications, based upon proposed antimicrobial, antitussive, spasmolytic, and antioxidant activity. Thyme tea is regarded in European culture as a classic remedy for upper respiratory tract infections including colds, flu, bronchitis, and strep throat. Preparations have traditionally included infusions, syrups, lozenges, and tinctures across European and Mediterranean herbal traditions.

Scientific Evidence: A clinical trial investigating a combination of Thymus vulgaris and primrose dry powder extract in bronchitis patients found that an oral dose of 160 mg thyme and 60 mg primrose root extract for 11 days reduced cough symptoms on day 9 with an efficacy of 73.7% compared with placebo (day 11; 57.8%) (p < 0.0001); reduction of bronchitis severity score was observed only after 4 days with thyme and primrose treatment (−6.2) compared with placebo (−4.1) (p < 0.05). The combination of ivy/primrose/thyme combines secretolytic and spasmolytic effects from ivy with antibacterial effects from thyme. To date there are no well-defined controlled clinical trials to support thyme monotherapy for therapeutic use in humans. Evidence for thyme in combination preparations for bronchitis is emerging and promising, but it is moderate in quality; monotherapy evidence remains lacking.

Andrographis paniculata

Traditional Use: Andrographis paniculata is an extremely bitter herb of which the aerial parts — and sometimes the roots — are used in Ayurveda, Siddha, homeopathy, naturopathy, and traditional Chinese and Thai medicine for various indications.

Scientific Evidence: A systematic review and meta-analysis of clinical trials showed that A. paniculata significantly improved overall symptoms of acute upper respiratory tract infections; specifically, it improved cough (n=596, SMD: −0.39, 95% CI: −0.67, −0.10; p=0.008) and sore throat (n=314, SMD: −1.13, 95% CI: −1.37, −0.89; p<0.00001), and significantly shortened the duration of these symptoms when compared to standard treatment, with no major adverse effects found. Mechanistically, A. paniculata acts through immunomodulation and antiviral activity, possibly supplemented by antibacterial and antipyretic effects. Evidence is from several RCTs and meta-analyses; most trials focus on upper respiratory tract infections, and evidence specific to bronchitis is limited.

Echinacea spp.

Traditional Use: Echinacea species were used by Indigenous North American peoples for a wide range of conditions involving infections; roots were prepared as decoctions and applied to wounds and infections. In European phytomedicine, echinacea preparations have been widely adopted since the late 19th century for immune support during colds and respiratory infections.

Scientific Evidence: Echinacea species likely act through immunomodulation. Andrographis paniculata, Pelargonium sidoides, Echinacea species, and a combination of ivy, primrose, and thyme have promising clinical effects in uncomplicated, acute upper respiratory tract infections treatment. Echinacea has been extensively studied in the context of the common cold and upper respiratory infections broadly. Evidence for its use specifically in acute bronchitis is less direct, and Cochrane reviews of echinacea for common cold note modest, inconsistent benefits with methodological variability among trials.

6. Dietary Patterns and Lifestyle Factors

Antioxidant-Rich Diets and Fruit/Vegetable Intake

There is evidence to support the link between the consumption of antioxidant-rich food — e.g., fruit and vegetables — and the occurrence of obstructive airway disease; the intake of antioxidant-rich foods has been evaluated and found to be positively associated with lung function; the relation between the consumption of fresh fruit and pulmonary function is dose-dependent; epidemiological studies indicate that forced expiratory volume in 1 second (FEV1) varies between COPD patients who consume fresh fruit more than once a day versus less than once a month. Epidemiological research suggests that lifestyle factors like physical inactivity and poor nutrition contribute to the severity of chronic respiratory diseases; a composite dietary antioxidant index (CDAI) is negatively associated with the prevalence of chronic respiratory diseases (especially emphysema and chronic bronchitis).

The Mediterranean Diet

The Mediterranean diet appears to be of benefit in patients with airways disease, and there appears to be a beneficial effect in smokers; however, there is no direct evidence regarding protection against air pollution. Diets rich in polyphenols, vitamins C and E, fiber, and omega-3 fatty acids are known to modulate inflammatory cascades, improve endothelial function, and enhance host antioxidant defenses.

Omega-3 Fatty Acids in Diet

The Mediterranean diet recommends the consumption of nuts and fish as they are rich sources of omega-3 fatty acids. Diets rich in polyphenols, vitamins C and E, fiber, and omega-3 fatty acids are known to modulate inflammatory cascades and enhance host antioxidant defenses; these pathways may be especially relevant in populations exposed to chronic environmental pollutants, which have been shown to induce oxidative lung damage and airway remodeling.

Sodium and Fluid Intake

A high intake of sodium leads to fluid retention, pulmonary hypertension, electrolyte imbalance, and elevated risk of edema that exacerbates COPD; lower intake of sodium in the DASH diet reduces airway inflammation and improves lung function. These findings are from review and epidemiological data and require further confirmatory research specific to bronchitis populations.

Dietary Patterns: Prudent Diet

The Prudent diet is an advantageous diet known as a preventive factor for chronic diseases; it is characterized by fresh vegetables and fruits, whole grains, legumes, nuts, and also low-to-moderate amounts of seafood and low-fat dairy products.

Smoking Cessation and Lifestyle

Several factors, including smoking and air pollution, have been shown to increase systemic oxidative stress in patients with COPD, and antioxidant supplementation can improve COPD symptoms. Unless some other factor can be isolated as the irritant that produces the symptoms, the first step in dealing with chronic bronchitis is for the patient to stop smoking.

Nutrition, Epigenetics, and Chronic Bronchitis

The relation between dietary intake and epigenetic factors has outlined nutriepigenomics as a possible missing link in the relation between environmental exposure to smoke and the appearance of subsequent chronic bronchial obstruction; available evidence regarding the influence of dietary patterns, nutrients, and epigenetic regulatory mechanisms on COPD development and prevention encourages future clinical research on the impact of dietary modifications on COPD-related clinical outcomes.

Summary of Evidence Strength

Pelargonium sidoides (EPs 7630): Moderate evidence from multiple RCTs and a Cochrane review supporting symptom reduction in acute bronchitis. Most robust herbal evidence in this indication.
Thyme (in combination): Preliminary-to-moderate evidence from RCTs for combination preparations (with ivy or primrose); monotherapy evidence is absent in controlled trials.
Ivy leaf (Hedera helix, in combination): Weak-to-preliminary evidence; most studies lack placebo controls; combination with thyme has one placebo-controlled RCT supporting cough reduction.
Andrographis paniculata: Moderate evidence from meta-analyses for upper respiratory tract infections; direct bronchitis-specific evidence is limited.
Vitamin C: Modest reduction in ARI risk and duration in meta-analyses of RCTs; evidence for chronic bronchitis/COPD is largely observational.
Vitamin D: Observational association between deficiency and increased ARI/bronchitis risk is well-established; interventional benefit in the general (non-deficient) population remains inconclusive.
Zinc: Reduction in ARI duration demonstrated in meta-analyses of RCTs; effect on ARI incidence not established.
Omega-3 fatty acids and antioxidant-rich diets: Epidemiological and observational evidence supports a protective association for chronic respiratory disease; large interventional trials specific to bronchitis are lacking.

References

Natural Remedies

Remedy 1

Raw Honey: Honey has long been used as a natural cough soother with antimicrobial, anti-inflammatory, and antioxidant properties that can help reduce coughing spells and soothe an irritated throat. Take a spoonful of raw honey on its own, stir it into warm herbal tea, or mix it with warm lemon water two to three times daily for best relief.

Remedy 2

Steam Inhalation: Inhaling steam loosens mucus in congested airways, reduces coughing, and eases chest congestion associated with bronchitis. Lean over a bowl of hot water with a towel draped over your head, breathe deeply for 10–15 minutes, and optionally add a few drops of eucalyptus oil to enhance the mucus-clearing effect.

Remedy 3

Ginger Tea: Ginger is a natural anti-inflammatory with expectorant properties that help thin and expel mucus while soothing the throat and reducing the severity of bronchitis symptoms. Boil fresh sliced ginger in water for five minutes, strain, add honey to taste, and sip two to three cups daily.

Remedy 4

Turmeric Golden Milk: Turmeric contains curcumin, a potent anti-inflammatory and antioxidant compound that helps reduce inflammation in the respiratory system and supports recovery from bronchitis. Stir one teaspoon of turmeric powder into a warm glass of milk (dairy or plant-based) and drink it two to three times a day — a practice rooted in Ayurvedic tradition.

Remedy 5

Garlic: Garlic is a well-established antiviral and antibacterial agent whose active compounds can help fight the infections underlying acute bronchitis and boost overall immune function. Add freshly minced garlic generously to soups, broths, stir-fries, or meals daily; for a stronger effect, eat a raw clove dipped in honey.

Remedy 6

Thyme Herbal Tea: Thyme has antispasmodic properties that help reduce coughing, while its active compounds support the loosening and clearing of mucus from the airways. Steep one teaspoon of dried thyme in a cup of hot water for 10 minutes, strain, add honey, and drink two to three times daily to ease bronchial spasms.

Remedy 7

Saltwater Gargle: Gargling with warm salt water soothes throat inflammation caused by chronic coughing and helps cut through mucus that irritates the throat and upper airways. Dissolve one teaspoon of salt in a glass of warm water and gargle for 30 seconds, repeating several times throughout the day as needed.

Remedy 8

Rest and Elevated Sleep Position: Adequate rest is essential when the body is fighting a bronchial infection, as it conserves energy and allows the immune system to focus on recovery. Allow yourself extra sleep and naps during the day, and sleep with your head elevated on an extra pillow to help reduce nighttime congestion and coughing.

Remedy 9

Warm Fluid Hydration: Staying well hydrated with warm fluids helps thin and loosen mucus, making it easier to expel, while also keeping the throat moist and reducing irritation. Aim for 8–10 glasses of water daily and supplement with warm herbal teas, clear broths, and hot water with lemon and honey throughout the day.

Remedy 10

Avoid Airway Irritants and Anti-Inflammatory Diet: Steering clear of cigarette smoke, dust, and environmental pollutants prevents further inflammation of the already-irritated bronchial tubes and reduces symptom severity. Support recovery from the inside by eating a diet rich in antioxidant fruits and vegetables, anti-inflammatory spices like ginger and turmeric, and lean proteins, while limiting sugary and highly processed foods that can suppress immune function.

Ingredients

These ingredients are often used in alternative medicine to support bronchitis.

andrographisScientific
Andrographis paniculata has strong evidence from systematic reviews for relieving symptoms of acute respiratory tract infections including bronchitis. Its active compound andrographolide acts via immunomodulation and antiviral/antibacterial effects. A 2023 systematic review confirmed its mechanistic and clinical plausibility for uncomplicated acute respiratory infections.
andrographolideScientific
Andrographolide is the principal active diterpene lactone of Andrographis paniculata and the mechanistic basis for the herb's clinical efficacy in acute respiratory infections including bronchitis. It exerts immunomodulatory and antiviral effects confirmed by a 2023 systematic review. NF-κB inhibition is the key anti-inflammatory pathway.
astragalusScientific
Astragalus (Astragalus membranaceus, Huang Qi) is extensively used in TCM as an immune-modulating herb for chronic respiratory conditions including bronchitis. Systematic reviews of Chinese clinical trials support its use for reducing bronchitis exacerbations and improving respiratory immune function. A double-blind RCT found 3 g daily for 8 weeks significantly reduced exacerbation frequency.
boswelliaScientific
Boswellia (Boswellia serrata, Indian frankincense) has demonstrated anti-inflammatory efficacy in respiratory inflammatory conditions including chronic bronchitis and asthma. A placebo-controlled RCT (40 asthmatic patients, 300 mg three times daily for 6 weeks) showed significant improvement in FEV1, PEF, and attack frequency. Its boswellic acids inhibit 5-lipoxygenase, reducing LTB4, a key mediator of bronchial inflammation.
boswellic acidScientific
Boswellic acids are the primary active triterpenoids of Boswellia serrata with demonstrated inhibition of 5-lipoxygenase, reducing leukotriene B4 production in bronchial inflammation. A placebo-controlled clinical trial showed 70% improvement in respiratory function in patients receiving Boswellia extract standardized to boswellic acids vs. 27% in placebo. They are the mechanistic basis for Boswellia's anti-inflammatory use in bronchitis and asthma.
bromelainScientific
Bromelain, the proteolytic enzyme complex from pineapple, has demonstrated therapeutic benefits for bronchitis and sinusitis through mucolytic, anti-inflammatory, and immunomodulatory mechanisms. German Commission E recognizes bromelain for inflammation of the upper and lower respiratory tract. Evidence reviews document its efficacy for reducing sputum viscosity and bronchial inflammation.
butterburScientific
Early clinical research, including the Ziolo & Samochewiec (1998) study, demonstrated that petasites extract improved lung ventilation markers and reduced bronchial reactivity in patients with chronic obstructive bronchitis. RxList and MSKCC note early evidence for this use. The antispasmodic and anti-inflammatory mechanisms are the same as those relevant to asthma.
carvacrolScientific
Carvacrol is the secondary major phenol in thyme oil alongside thymol, contributing to thyme's Commission E-approved use for bronchitis. It has demonstrated antimicrobial, anti-inflammatory, and bronchospasmolytic properties in preclinical studies. It is also the primary active constituent of oregano essential oil traditionally used for respiratory conditions.
chymotrypsinScientific
Chymotrypsin has documented use as a mucolytic and anti-inflammatory agent in bronchitis, used via inhalation or orally to reduce airway inflammation and loosen phlegm. Authoritative sources including WebMD and RxList reference this clinical use. The mucolytic mechanism is well-characterized: chymotrypsin directly decreases mucus viscosity.
cineoleScientific
Cineole (1,8-cineole/eucalyptol) is the main constituent of eucalyptus oil with specific clinical evidence for acute bronchitis from a placebo-controlled double-blind RCT (PMC3842692) demonstrating significantly faster dissipation of acute bronchitis symptoms versus placebo. It acts as a mucolytic, bronchodilator, and NF-κB-inhibiting anti-inflammatory agent.
cordycepsScientific
Cordyceps (Cordyceps sinensis/militaris) is used in Traditional Chinese Medicine for chronic bronchitis, cough, and asthma, supported by clinical studies and systematic reviews showing improvement in respiratory function. Multiple clinical trials report reductions in chronic bronchitis exacerbations and improved FEV1, FVC, and exercise capacity with Cordyceps preparations.
curcuminScientific
Curcumin is included in the 2025 Frontiers in Pharmacology PROSPERO-registered systematic review on chronic bronchitis. A 2026 Nutrients review rated Curcuma longa (curcumin source) as having robust clinical evidence for RTIs. It inhibits NF-κB, reduces bronchial cytokine production, and suppresses mucin gene expression and goblet cell hyperplasia relevant to bronchitis pathology.
echinaceaScientific
Echinacea species are among the best-studied botanicals for immune support in respiratory infections including acute bronchitis. A 2023 systematic review placed Echinacea alongside Andrographis and Pelargonium as herbs with promising clinical effects in acute uncomplicated respiratory tract infections. A 2026 Nutrients review rated Echinacea spp. as having robust clinical evidence for RTIs.
echinacea purpureaScientific
Echinacea purpurea is the most studied Echinacea species for respiratory tract infections including bronchitis. Multiple RCTs and systematic reviews, including Cochrane assessments, found statistically significant reductions in respiratory infection symptom duration and severity. Its polysaccharides and alkylamides drive immunostimulation and anti-inflammatory effects in bronchial tissue.
elderScientific
Elder (Sambucus nigra) berries and flowers are supported by robust clinical evidence for respiratory tract infections including bronchitis per a 2026 Nutrients systematic review. Multiple RCTs demonstrate reduction in respiratory infection duration and severity. EMA recognizes elderflower as a traditional herbal medicine for upper respiratory catarrh.
elderberryScientific
Elderberry (Sambucus nigra) is supported by robust clinical evidence for respiratory tract infections. A 2026 Nutrients systematic review rated it alongside Echinacea and Pelargonium as having robust evidence for RTIs. A meta-analysis of four RCTs (1,016 participants) found elderberry substantially reduced upper respiratory symptoms by a mean of 3.86 days.
ephedrineScientific
Ephedrine is the primary alkaloid of Ephedra sinica with well-characterized bronchodilatory activity via beta-adrenergic receptor stimulation. It is pharmacologically validated for bronchospasm relief relevant to bronchitis. Its mechanism is analogous to synthetic bronchodilators used in conventional medicine and it has been used clinically as a bronchodilator for decades.
eucalyptusScientific
Eucalyptus oil and its primary constituent cineole have clinical evidence for acute bronchitis from a double-blind RCT showing significantly faster symptom resolution. German Commission E and EMA support eucalyptus for respiratory tract catarrh. A 2025 Frontiers systematic review identifies Eucalyptus globulus among 13 medicinal plants with evidence for chronic bronchitis.
european elderScientific
European Elder (Sambucus nigra) shares the same botanical species and clinical evidence base as Elderberry for respiratory tract infections including bronchitis. A 2026 Nutrients review rated Sambucus nigra as having robust clinical evidence for RTIs alongside Echinacea and Pelargonium. EMA recognizes elderflower as a traditional herbal medicinal product for upper respiratory catarrh.
fritillaryScientific
Fritillary is explicitly documented in clinical TCM practice for bronchitis, with phytochemical evidence showing suppression of bronchial inflammation. Pharmacological reviews identify FRC and FRT as having notable effects on bronchitis. The herb inhibits mucin gene expression in bronchial epithelial cells and reduces pro-inflammatory cytokines.
garlicScientific
Garlic (Allium sativum) inhibited infectious bronchitis virus in a 2016 peer-reviewed study and is listed among proposed treatments for bronchitis in multiple authoritative sources. It has long-standing traditional use across Ayurveda, TCM, and European herbal medicine for respiratory infections. Allicin and organosulfur compounds provide antimicrobial, antiviral, and anti-inflammatory effects.
garlic bulbScientific
Garlic bulb (Allium sativum) has direct laboratory evidence inhibiting infectious bronchitis virus (2016, Avicenna Journal of Phytomedicine, PMID 27516987). It is listed in authoritative traditional medicine reviews as a bronchitis remedy. Allicin and diallyl sulfide constituents provide antiviral, antibacterial, and expectorant activity relevant to acute bronchitis.
geraniumScientific
Pelargonium sidoides (EPs 7630) has strong clinical trial and Cochrane review evidence for acute bronchitis in adults and children. The EMA has approved P. sidoides for respiratory tract infections including bronchitis. This is one of the best-evidenced herbal remedies for this condition.
ginsengScientific
Ginseng (Panax ginseng, American ginseng) has clinical evidence for reducing respiratory tract infections and improving respiratory immune function. A 2026 Nutrients review included ginseng-related compounds among clinically evaluated plant agents for RTIs. A double-blind RCT (323 adults) found American ginseng extract significantly reduced incidence and duration of respiratory illness. It is used in TCM for chronic bronchitis.
glehnia littoralisScientific
G. littoralis is formally documented in Chinese clinical practice for chronic bronchitis and is listed in the Chinese Pharmacopoeia for lung conditions. The 2024 PMC study (PMC11547663) and ScienceDirect 2023 review both cite chronic bronchitis as a recognized clinical application. Antitussive and anti-inflammatory preclinical evidence supports this use.
glycyrrhetinic acidScientific
Glycyrrhetinic acid is the hydrolysis product of glycyrrhizin from licorice root, acting as the pharmacologically active aglycone mediating most of glycyrrhizin's anti-inflammatory effects in bronchial tissue. It potentiates endogenous cortisol via 11β-HSD2 inhibition and inhibits NF-κB and phospholipase A2, providing corticosteroid-like bronchial anti-inflammatory effects.
glycyrrhizinScientific
Glycyrrhizin is the primary active compound of licorice root with demonstrated antiviral, anti-inflammatory, and expectorant properties relevant to bronchitis. It inhibits NF-κB and reduces mucus hypersecretion. NCCIH documents it as the main bioactive constituent of licorice, which is recognized by Commission E and ESCOP for upper respiratory catarrh.
honeyScientific
Honey is supported by a clinical randomized trial for managing acute bronchitis. A 2023 multiarm RCT (Llor et al., Family Practice) compared honey versus antitussives and anticholinergics for uncomplicated acute bronchitis, finding honey to be an effective usual-care alternative. WHO endorses honey as a demulcent for cough and respiratory tract irritation.
horseradishScientific
Clinical evidence supports the combination of horseradish root and nasturtium (Angocin Anti-Infekt N) for acute bronchitis. A prospective cohort study of 634 bronchitis patients found efficacy comparable to antibiotics with fewer adverse effects. A separate randomised placebo-controlled trial (n=384) confirmed healing benefit. Evidence is for the combination product.
ivyScientific
Ivy leaf (Hedera helix) extract is clinically authorized in several European countries as a medicinal product specifically for acute bronchitis. A 2025 three-arm multicenter RCT (325 adults) demonstrated ivy extract was non-inferior to Ivy/Thyme and Thyme/Primrose combinations on the Bronchitis Severity Score at day 7. Its saponin hederacoside C provides secretolytic and spasmolytic effects in bronchial tissue.
L-cystineScientific
As a precursor to cysteine and thus to NAC, L-cystine underpins the mucolytic, antioxidant, and anti-inflammatory mechanisms relevant to bronchitis management. NAC—the clinically validated cysteine prodrug—has documented RCT and regulatory evidence for both acute and chronic bronchitis. Direct L-cystine bronchitis trials are not available, but the mechanistic lineage is biochemically direct.
luteolinScientific
Luteolin is the subject of a dedicated 2025 Frontiers in Pharmacology review on its regulatory mechanisms in inflammatory respiratory diseases. It inhibits NF-κB and PI3K/Akt pathways in bronchial inflammation models and is cited in the 2025 chronic bronchitis systematic review as a flavonoid with demonstrated effects in inflammatory respiratory conditions.
malabar nutScientific
Malabar nut (Justicia adhatoda, Vasaka) is used in Ayurvedic and Unani medicine specifically for bronchitis, with the Indian Pharmacopoeia listing Vasaka syrup and liquid extract for respiratory use. Primary alkaloids vasicine and vasicinone have demonstrated bronchodilatory and expectorant effects in vitro and in vivo. It is used in commercial respiratory preparations in India, Germany, and Sweden.
NAC (N-acetyl cysteine)Scientific
NAC has extensive RCT evidence for both acute and chronic bronchitis. A meta-analysis of 11 RCTs (775 patients) found NAC significantly reduced chronic bronchitis exacerbation frequency (RR=0.81). A second meta-analysis of 13 studies (4,155 patients) confirmed fewer exacerbations (RR=0.75, p<0.01). A double-blind RCT found 200 mg NAC thrice daily significantly reduced cough, sputum volume, and viscosity in acute bronchitis.
naringinScientific
Naringin is specifically documented in the 2025 Frontiers in Pharmacology PROSPERO-registered systematic review on chronic bronchitis. In guinea pig models of cigarette smoke-induced chronic bronchitis, naringin significantly reduced inflammatory cell counts, cytokines (IL-8, TNF-α), MPO activity, and cough frequency while enhancing antioxidant activity in bronchial tissue.
pelargoniumScientific
Pelargonium sidoides root extract (EPs 7630) is one of the best-evidenced herbal treatments specifically for acute bronchitis, with multiple placebo-controlled RCTs and systematic reviews demonstrating significant symptom relief. A 2026 Swiss pragmatic RCT further validated its use versus usual care. It acts through antiviral, indirect antibacterial, immunomodulatory, and expectorant mechanisms.
plantagoScientific
Both P. major and P. lanceolata have clinical trial evidence in bronchitis. A double-blind RCT with P. major syrup showed significant reduction in cough severity (BSS score) in acute bronchitis. An older trial in chronic bronchitis with P. major preparation showed rapid improvement in 80% of patients. Commission E and ESCOP endorse P. lanceolata for catarrh of the airways.
plantainScientific
A double-blind randomized controlled trial tested Plantago major syrup (30 ml/day for 10 days) in 80 patients with acute bronchitis. The P. major group showed significantly lower Bronchitis Severity Scale scores, cough frequency, sputum volume, and chest wall pain compared to placebo. This represents direct clinical evidence for P. major in bronchitis.
platycodon rootScientific
Platycodon root is formally indicated for bronchitis in TCM, Kampo, and Korean traditional medicine, with the Chinese Pharmacopoeia and ethnopharmacological records confirming millennia of use. A 2025 ScienceDirect study found platycodon mitigates cigarette smoke-induced chronic bronchitis inflammation via TLR4/MyD88/NF-κB pathway inhibition. Network pharmacology and phytochemical studies have mapped its multi-target mechanisms.
quercetinScientific
Quercetin is specifically included in the 2025 Frontiers in Pharmacology PROSPERO-registered systematic review on chronic bronchitis. A preclinical study showed quercetin at 0.05–0.1 g/kg for 5 days reduced cough frequency comparably to pentoxyverine citrate in bronchitis models. It also suppresses mucin expression, a hallmark of chronic bronchitis.
serratiopeptidaseScientific
Serratiopeptidase has been clinically studied for bronchitis and chronic airway disease, with evidence for reducing sputum viscosity, elasticity, and neutrophil count. A 2003 randomized open-label trial (Nakamura et al., Respirology, n=29) found 30 mg/day for 4 weeks decreased sputum weight, viscosity, and elasticity versus no treatment. It has been used clinically for bronchitis in Japan and Europe for decades.
thymeScientific
Thyme (Thymus vulgaris) is approved by the German Commission E specifically for symptoms of bronchitis and whooping cough. A large 361-patient double-blind placebo-controlled study found a thyme-primrose root combination significantly enhanced recovery from acute bronchitis. A 2025 three-arm RCT (325 adults) confirmed thyme/primrose non-inferior to ivy extract on Bronchitis Severity Score.
thymolScientific
Thymol is the primary active phenol of thyme oil with documented antimicrobial, expectorant, and bronchospasmolytic effects that underlie thyme's Commission E-approved use for bronchitis. It is the key constituent responsible for thyme's clinical efficacy in bronchitis preparations registered in Germany, confirmed by a 2023 mechanistic systematic review.
thymusScientific
Bronchitis is the most robustly evidenced clinical indication for Thymus vulgaris, with multiple prospective double-blind placebo-controlled multicentre RCTs demonstrating significant reductions in cough frequency and bronchitis severity scores. Both German Commission E and ESCOP monographs formally approve thyme for bronchitis. Thymol's secretolytic, spasmolytic, and antimicrobial mechanisms are well characterised.
tinospora cordifoliaScientific
Ethanolic extract of T. cordifolia is an ingredient in 'Septilin,' a commercial Ayurvedic formulation recommended and used clinically for bronchitis treatment. Its anti-inflammatory and antimicrobial properties support this use.
vasicineScientific
Vasicine is the primary alkaloid of Adhatoda vasica (Malabar nut) with demonstrated bronchodilatory, expectorant, and anti-tussive activities in vitro and in vivo. It is the pharmacopoeial active constituent in Vasaka syrup (Indian Pharmacopoeia) specifically for bronchitis. It is the structural precursor of bromhexine, a widely used pharmaceutical mucolytic for bronchitis.
vasicinoneScientific
Vasicinone is the principal metabolite of vasicine from Adhatoda vasica with demonstrated in vitro bronchodilatory activity. It is documented alongside vasicine as a therapeutic agent for bronchitis in patent literature (US Patent 11351213). It is also a recognized pharmacologically active compound in Ayurvedic Vasaka preparations listed in the Indian Pharmacopoeia.
abies spectabilisTraditional
Traditional Himalayan and Indian medicine uses A. spectabilis leaf juice and essential oil for bronchitis. This is documented in multiple ethnobotanical surveys of Nepal. Preclinical antitussive and bronchodilatory data provide biological plausibility.
ajwainTraditional
Ajwain is widely used in traditional Ayurvedic and Unani medicine for bronchitis, leveraging its bronchodilatory, expectorant, and antimicrobial properties. Steam inhalation with ajwain is a traditional home treatment for bronchitis symptoms. While bronchodilatory effects have clinical evidence, bronchitis-specific clinical trials are absent.
alkanetTraditional
Alkanet is traditionally used internally for bronchitis, bronchial catarrh, and persistent cough. All plant parts are described as demulcent and expectorant in herbal references. Use for bronchial inflammation is documented in European folk medicine and in Indian traditional medicine (ratanjot).
alpinia galangalTraditional
Galangal rhizome is used in Indian indigenous medicine, Ayurveda, and TCM for bronchitis and bronchial catarrh. In Indian medicine it is classified as an expectorant and decongestant. It appears in traditional formulations for respiratory complaints including chronic bronchitis. No dedicated human trials exist.
anemarrhena asphodeloidesTraditional
Anemarrhena has a documented traditional history of use for chronic and acute bronchitis in TCM and East Asian medicine. Its actions of moistening the lungs, clearing heat, and antibacterial properties against Staphylococcus aureus and other pathogens underlie this traditional use.
annattoTraditional
Use of annatto leaf preparations as expectorants and for treatment of bronchitis, cough, and pulmonary disorders is documented in Latin American traditional medicine. Leaves and seeds are described as expectorant and cardiotonic in multiple indigenous compendia. No human clinical evidence is available.
apricotTraditional
Bitter apricot kernel (xing ren) is used in TCM for bronchitis as an antitussive and expectorant. TCM clinical use lists bronchitis among its primary indications. The kernel promotes mucus clearance from the respiratory tract and has been incorporated in herbal preparations for bronchial conditions. Traditional use spans Chinese, Persian, and other Asian medical systems.
asparagusTraditional
Traditional use of asparagus roots for bronchial conditions, including bronchial asthma and cough, is documented across multiple cultures. A. cochinchinensis dried roots have been listed in the Chinese Pharmacopoeia for asthma and cough since 1977. European traditional practice recorded use for 'bronchial asthma'. No clinical trial evidence exists.
aster rootTraditional
Aster root has 2,000-plus years of documented use in TCM, Korean, and Japanese traditional medicine specifically for bronchitis management. Traditional use for chronic bronchitis is particularly well-documented across Asian medical traditions. Preclinical evidence from cell and animal models supports anti-inflammatory activity along the bronchitis-relevant TLR4/MyD88/NF-κB pathway, though no human bronchitis trials exist.
balloon flowerTraditional
Balloon flower (Platycodon grandiflorus) root is a core Traditional Chinese and Korean medicine herb for bronchial congestion and bronchitis, used to expel phlegm and open the lungs. The 2025 Frontiers in Pharmacology systematic review on chronic bronchitis identifies its polysaccharides and platycodin D as suppressing mucin expression. Classified as an expectorant in both Chinese and Korean Pharmacopoeias.
bambooTraditional
Bamboo sap (Succus Bambusae/zhuli) and tabasheer (tianzhuhuang) are used in TCM for acute bronchitis, as documented in classical Chinese medical texts and modern TCM clinical practice. The ITM Online reference notes bamboo sap is used clinically for pneumonia and acute bronchitis. Indian traditional medicine similarly uses bamboo formulations for bronchial infections.
basilTraditional
Basil is documented in traditional medicine across India, Brazil, and Africa for bronchitis and cough. The Frontiers in Pharmacology systematic review confirmed traditional use for bronchitis in multiple countries. Bronchodilatory properties of linalool metabolites provide pharmacological plausibility.
bayberryTraditional
Bayberry leaf tea was historically used for bronchitis as part of North American folk medicine traditions. TCM also records bayberry use for respiratory inflammation. The herb's expectorant and astringent properties underpin this traditional use. No clinical evidence exists.
belleric myrobalanTraditional
Belleric myrobalan is consistently cited for bronchitis across Ayurvedic, Unani, Siddha, and traditional Chinese medicine systems. The Chinese Pharmacopeia specifically lists T. bellirica for treating bronchitis. Its bronchodilatory, antispasmodic, and antimicrobial properties provide mechanistic support. Traditional use for bronchial conditions is among the most consistently documented applications of this herb.
black spruceTraditional
Bronchitis is listed in multiple pharmacopoeia and aromatherapy references for black spruce. Its mucolytic (camphene), expectorant, and anti-inflammatory properties (bornyl acetate) are well established in traditional herbalism. The School of Aromatic Studies specifically lists it for bronchitis.
blackboard treeTraditional
A. scholaris bark is traditionally indicated for bronchitis and chronic respiratory conditions in Ayurvedic, Unani, and Chinese medical systems. Its antitussive and expectorant activities have been confirmed in animal models, lending preclinical support, though no human clinical trials targeting bronchitis specifically have been published.
bonesetTraditional
Boneset has a documented traditional role in acute bronchitis, attributed to its diaphoretic and mild expectorant actions. Lockwood's 1847 medical report (archived in PMC) listed bronchitis among its primary indications. Modern herbalists continue to use it for acute bronchitis with fever and mucus congestion. No clinical trials for bronchitis specifically have been performed.
borageTraditional
Borage leaf has a well-documented traditional use for bronchitis, colds, and respiratory catarrh, recorded across European, Mediterranean, and other herbal traditions. It was used as an expectorant and anti-inflammatory. Traditional herbal monographs consistently cite this respiratory indication.
cajuputTraditional
Cajuput oil is a well-documented traditional remedy for bronchitis across Southeast Asia and in European herbal practice, where it was historically valued as an inhalant. Its major constituent 1,8-cineole has clinical evidence (in pharmaceutical form) for improving bronchitis symptoms in RCTs, though these studies used isolated cineole, not cajuput oil itself. Cajuput is an ingredient in OTC bronchitis inhalant products.
camphor oilTraditional
Camphor has extensive traditional use for bronchitis across Asian and European medicine. Historical pharmacological texts report good outcomes for acute bronchitis. The Drugs in Context 2022 clinical review assessed a camphor-containing ointment for bronchial catarrh and hoarseness with high tolerability ratings. However, bronchitis-specific clinical trial evidence for camphor alone is lacking.
carawayTraditional
Caraway is traditionally used for bronchitis and respiratory infections in European and Ayurvedic herbal medicine. Its expectorant and antimicrobial properties are the basis for traditional use. A peer-reviewed scientific source confirms use in bronchopulmonary disorders as a cough remedy.
cardamomTraditional
Cardamom has traditional use in Ayurvedic and South Asian medicine for bronchitis, bronchial congestion, and respiratory infections. Its expectorant, anti-inflammatory, and antimicrobial properties—primarily attributed to 1,8-cineole—provide pharmacological rationale. Clinical trial data specifically for bronchitis are absent.
chaff flowerTraditional
A. aspera is widely documented for bronchitis use in Ayurveda, Siddha, Unani, and African folk systems. Its bronchodilator and anti-inflammatory properties provide pharmacological rationalization, but no specific bronchitis clinical study exists.
chamomileTraditional
Germany's Commission E has formally approved chamomile for the treatment of coughs and bronchitis, representing one of the highest-quality regulatory endorsements of traditional use. Chamomile steam inhalation is a documented traditional application for bronchitis, colds, and mucous congestion. Human clinical trials specifically for bronchitis are absent.
chen piTraditional
Chen Pi is traditionally listed in Chinese Materia Medica for chronic bronchitis and is used in clinical TCM practice for cough with profuse phlegm. Its mucolytic volatile oils and anti-inflammatory flavonoids provide mechanistic rationale, though isolated clinical trials are unavailable.
chickweedTraditional
Chickweed is consistently cited in herbal traditions and ethnobotanical records as a remedy for bronchitis, valued for its combined expectorant and soothing demulcent actions on the bronchial airways. Multiple herbal monographs document this use. No clinical evidence is available.
citrus sinensisTraditional
C. sinensis has a documented history of traditional use for bronchitis, cough, and respiratory congestion across European and Chinese herbal medicine. Grieve's classic herbal describes oils from oranges for chronic bronchitis. No dedicated human clinical RCTs on C. sinensis for bronchitis have been identified.
clerodendrum indicumTraditional
Clerodendrum indicum is explicitly listed in traditional systems of medicine for the treatment of bronchitis. The root and leaf juice mixed with ghee or ginger form the classical preparations used across India and Southeast Asia. This use is consistently documented across multiple ethnobotanical sources but lacks clinical validation.
cloveTraditional
Clove is traditionally used for bronchitis in Ayurvedic and folk medicine. Eugenol's anti-inflammatory, antimicrobial, and expectorant properties are relevant to bronchitis pathology.
coltsfootTraditional
Coltsfoot is among the most historically prominent herbs for bronchitis in both European and Chinese herbal medicine. In Europe, the leaves are used to treat bronchial infections; in China, the flower buds are preferred for acute and chronic bronchitis. No independent clinical trials exist.
comfreyTraditional
Comfrey has a well-documented traditional use internally as an expectorant and soothing agent for bronchitis and dry cough, with its mucilaginous compounds coating irritated bronchial mucosa. Historical herbals and modern databases (RxList, drugs.com) list bronchitis among traditional indications. No clinical trials support this use, and oral comfrey is contraindicated due to pyrrolizidine alkaloid hepatotoxicity.
commiphoraTraditional
Commiphora myrrh has a well-documented traditional classification as an expectorant and antimicrobial agent for bronchitis across TCM, Ayurveda, Arabic, and European herbal medicine. ESCOP and historical pharmacopoeias recognize its respiratory applications. Clinical trial data is absent.
damianaTraditional
Damiana is listed in traditional medicine for coughs, bronchitis, and respiratory complaints. Maya Indians named it 'mis kok' meaning 'broom for asthma.' Traditional preparations include it as an expectorant and cough suppressant. No clinical studies on bronchitis exist.
dog roseTraditional
Dog Rose has documented traditional use for respiratory conditions including bronchitis across multiple ethnopharmacological sources. Rosa canina is classified in the IJPS Journal systematic review as traditionally used for 'respiratory conditions such as bronchitis and colds.' No human clinical trials for bronchitis specifically have been conducted.
elecampaneTraditional
Elecampane (Inula helenium) has a centuries-long specific traditional use for bronchitis-associated cough in Western herbal and Eclectic medicine. It is listed as a proposed bronchitis treatment by the EBSCO evidence database. Its sesquiterpene lactone alantolactone is anti-inflammatory and the inulin content provides mucilaginous expectorant action.
ephedraTraditional
Ephedra (Ephedra sinica, Ma Huang) has been used in Traditional Chinese Medicine for over 5,000 years for respiratory conditions including bronchitis and asthma. Its alkaloids ephedrine and pseudoephedrine are pharmacologically validated bronchodilators. German Commission E and WHO recognize Ephedra preparations for respiratory catarrh and cough.
ferula assafoetidaTraditional
Chronic bronchitis is a primary traditional indication for asafoetida documented across Ayurvedic, Unani, European, and Middle Eastern medicine. Expectorant activity via pulmonary elimination of volatile oil, smooth-muscle relaxation, and antimicrobial properties underpin this use.
forskohlii rootTraditional
C. forskohlii is historically documented in Ayurvedic medicine for bronchitis, sharing mechanistic overlap with its asthma indication via airway smooth-muscle relaxation. No clinical trials specifically for bronchitis have been identified.
forsythiaTraditional
Forsythia (Forsythia suspensa, Lian Qiao) is a key Traditional Chinese Medicine herb for acute respiratory infections including bronchitis and lung heat conditions. It is traditionally combined with honeysuckle in Yin Qiao San for respiratory infections. Its forsythosides and lignans have antiviral and anti-inflammatory activity. Evidence is primarily traditional and preclinical.
ganodermaTraditional
Ganoderma lucidum has a documented traditional Chinese medicine use for chronic bronchitis, with antitussive and bronchodilatory pharmacological properties identified in preclinical studies. Modern reviews affirm its potential for bronchitis management based on its anti-inflammatory and respiratory effects.
gingerTraditional
Ginger (Zingiber officinale) has traditional use in Ayurveda, TCM, and folk medicine specifically for bronchitis and cough. Anti-inflammatory effects in human bronchial epithelial cells (BEAS-2B) are published (Podlogar and Verspohl, 2012, Phytotherapy Research, PMID 21698672). Systematic reviews note limited high-quality RCT evidence for acute bronchitis specifically.
goldenrodTraditional
Goldenrod has traditional use for bronchitis as part of its documented role in upper respiratory catarrhal conditions. European and North American folk medicine list it for bronchial catarrh and associated cough. Its anticatarrhal and mild expectorant properties provide pharmacological plausibility. No clinical trials have evaluated goldenrod for bronchitis specifically.
goldensealTraditional
Goldenseal is traditionally used for bronchitis as part of its broader mucous membrane and respiratory tract indications. Its antimicrobial and mucolytic-adjacent properties are the rationale. No clinical trials have confirmed efficacy for bronchitis.
gooseberryTraditional
Traditional Ayurvedic and Unani medicine use amla for bronchitis and other respiratory conditions. A clinical study in volunteers with smoking-related respiratory compromise documented cardio-respiratory improvements. Anti-inflammatory and antioxidant mechanisms support this use.
greek mountain teaTraditional
Bronchitis is among the most consistently cited traditional indications for GMT across Balkan ethnobotany, referenced in both peer-reviewed literature and the EMA assessment process. GMT's expectorant, anti-inflammatory, and antimicrobial properties are directly relevant. No human RCT in bronchitis has been published.
green chirettaTraditional
Green chiretta is documented in both TCM and Ayurveda as a treatment for bronchitis and acute respiratory bacterial/viral infections. It is traditionally used to clear lung heat, resolve phlegm, and reduce inflammatory exudation in the bronchial tree. Clinical ARTI data broadly support an anti-inflammatory and antiviral role relevant to bronchitis, though no dedicated bronchitis-specific clinical trials were identified.
grindeliaTraditional
Grindelia (Grindelia squarrosa, gumweed) is a traditional North American herb used specifically for bronchitis, asthma, and respiratory catarrh in Native American and Eclectic medicine traditions. It was included in the US Pharmacopeia and National Formulary for respiratory conditions. Its resinous grindelane diterpenes relax bronchial muscle and saponins provide expectorant activity.
guggulTraditional
In Ayurveda, guggul is described as aromatic and expectorant, useful for Kapha-type respiratory disorders including bronchitis, cough, and nasal catarrh. Inhalation of guggul fumes is a traditional application for respiratory conditions. No clinical trials exist for this indication.
gumweedTraditional
Gumweed is another common name for Grindelia species, used traditionally for bronchitis and respiratory catarrh in North American herbal and Eclectic medicine. It was included in the US Pharmacopeia and National Formulary for respiratory indications and appears in authoritative herbal bronchitis treatment lists.
hedychium spicatumTraditional
Bronchitis is among the traditional indications of H. spicatum documented in multiple systematic reviews, including Rawat et al. (2018). The plant is used in Ayurvedic formulations for bronchial conditions, and antihistaminic/bronchodilator preclinical data provide indirect mechanistic support.
holarrhena antidysentericaTraditional
The leaves and bark of H. antidysenterica are used in Ayurvedic, Unani, and British Materia Medica traditions for chronic bronchitis and chest infections. No modern clinical trials for bronchitis have been published; the evidence is ethnopharmacological.
honey loquat syrupTraditional
Honey loquat syrup is a traditional Chinese medicine preparation combining honey and loquat leaf (Eriobotrya japonica) specifically used for bronchitis, cough, and respiratory inflammation. Loquat leaf is classified in TCM as an expectorant and anti-tussive herb. In vivo studies confirm antitussive and expectorant activities of loquat leaf decoction.
honeysuckleTraditional
Honeysuckle (Lonicera japonica, Jin Yin Hua) is a foundational herb in Traditional Chinese Medicine for acute respiratory infections including bronchitis, cough, and lung heat conditions. It is listed among plants used for chronic bronchitis in authoritative herbal reviews. Its chlorogenic acid, luteolin, and quercetin content provide anti-inflammatory and antiviral properties.
horehoundTraditional
White horehound (Marrubium vulgare) is listed in the EBSCO evidence database among proposed traditional bronchitis treatments. German Commission E approves horehound for non-productive cough and respiratory catarrh. Its diterpene marrubiin stimulates bronchial secretion, acting as a natural expectorant.
hyssopTraditional
Hyssop (Hyssopus officinalis) has a centuries-long traditional use for bronchitis, cough, and respiratory inflammation listed in the EBSCO evidence database among proposed treatments for cough and bronchitis. German Commission E and EMA approve it for catarrh of the upper respiratory tract and non-productive cough. Its volatile oil constituent pinocamphone has expectorant and antispasmodic effects.
immortelleTraditional
H. italicum EO has been traditionally used as an expectorant and for bronchitis. An in vitro study confirmed antibacterial and biofilm-inhibitory activity against respiratory tract pathogens including Haemophilus influenzae, Streptococcus pneumoniae, and Pseudomonas aeruginosa, providing partial scientific support for this traditional use.
indian frankincenseTraditional
Boswellia gum resin is documented in traditional Ayurvedic and Unani texts as a remedy for bronchitis and cough. It is listed alongside asthma among respiratory traditional indications. Anti-inflammatory 5-LOX inhibition is mechanistically relevant to airway inflammation in bronchitis.
indian gum arabic treeTraditional
Acacia nilotica leaves are traditionally employed to cure bronchitis across South Asian and African medicine. The plant's anti-inflammatory, antibacterial, and antispasmodic properties support this use. Traditional use for chest pain and respiratory complaints is documented.
indigo leavesTraditional
Indigo leaves are documented in traditional Indian (Ayurvedic, Siddha, folk) and traditional Chinese medicine for the treatment of bronchitis. Leaves are specifically mentioned as used for 'cough, bronchitis, and fever' in multiple ethnobotanical records. No clinical human trial data exist.
inula racemosaTraditional
I. racemosa is documented in Ayurvedic, Chinese Traditional Medicine, and Himalayan ethnomedicinal traditions for chronic bronchitis. The roots are classified as expectorant, bronchodilator, and anti-inflammatory in classical Ayurvedic texts. Scientific evidence is limited to animal and in vitro studies that support plausible mechanisms.
jiaogulanTraditional
Jiaogulan is listed as a traditional treatment for chronic bronchitis in both the RxList and Drugs.com medical monographs, reflecting documented historical use in Chinese folk medicine for respiratory conditions including cough and chronic bronchitis.
jujubeTraditional
Jujube is documented in traditional Korean, Chinese, and Ayurvedic medicine as effective for bronchitis, cough, and respiratory tract inflammation. Traditional pharmacopeia listings describe jujube syrup or decoction for throat irritation. No human clinical trials for bronchitis have been identified.
kavaTraditional
Kava has a documented traditional and historical use for bronchitis and respiratory tract conditions in Pacific Island and early Western herbal medicine, attributed to its anti-inflammatory, antimicrobial, and spasmolytic properties. No human clinical evidence supports this specific indication.
knotweedTraditional
Knotweed (Polygonum aviculare species) has been used traditionally for bronchitis and cough. In TCM, Hu Zhang (P. cuspidatum) is used to resolve phlegm and ease cough. WebMD's monograph notes knotweed is used for bronchitis but states there is no good scientific evidence. The Chinese Pharmacopoeia records its use for bronchitis and cough.
lemongrassTraditional
Lemongrass is recorded in folk medicine as an antitussive (anti-cough) and respiratory remedy, with use for bronchitis documented in some traditional contexts. C. citratus is classified as antitussive in scientific reviews of its folk-medicine attributes. Antimicrobial and anti-inflammatory properties provide mechanistic support but clinical trials are absent.
licorice rootTraditional
Licorice root (Glycyrrhiza glabra) is documented by NCCIH and multiple traditional medicine authorities for cough and respiratory inflammation including bronchitis. German Commission E and ESCOP recognize licorice for catarrh of the upper respiratory tract. Its glycyrrhizin, flavonoids, and isoflavones provide anti-inflammatory, demulcent, and expectorant effects.
lilacTraditional
Bronchitis is a documented traditional indication of Syringa species in both Chinese/Asian traditional medicine and, for cough, in European ethnopharmacology. The BMC Chemistry and ScienceDirect genus reviews specifically list bronchitis among conditions treated with Syringa species. Asian species (S. reticulata) are documented for bronchial disease.
lobeliaTraditional
Lobelia (Lobelia inflata) is a traditional North American herb used extensively by Eclectic physicians specifically for bronchitis, asthma, and spasmodic cough. Lobeline, its primary alkaloid, acts as a respiratory stimulant and bronchial antispasmodic. It is listed among proposed traditional treatments for cough related to bronchitis in authoritative evidence databases.
marjoramTraditional
Marjoram is documented in traditional European and Mediterranean herbal medicine for bronchitis, coughs, and chest congestion. Its expectorant classification and antimicrobial properties support this traditional application.
marshmallowTraditional
Marshmallow (Althaea officinalis) root has been used since ancient Greek and Egyptian times as a demulcent for bronchitis and cough. The EBSCO Research Starters evidence database lists it among proposed traditional bronchitis treatments. German Commission E recognizes marshmallow for dry irritative cough. Its high mucilage content coats and soothes inflamed bronchial mucous membranes.
menthol oilTraditional
Menthol has a long history of traditional use for bronchitis symptoms, particularly cough and chest tightness, via inhalation and topical chest application. Its TRPM8 activation suppresses cough reflex, but specific bronchitis clinical trials are not available.
milkweedTraditional
Milkweed (chiefly A. tuberosa) has deep traditional use for bronchitis in both Indigenous North American and European-derived herbal medicine. It was listed in the US Pharmacopeia and National Formulary for respiratory conditions including bronchitis. UK herbalists also used the dried root for bronchitis. No clinical evidence supports efficacy.
mulleinTraditional
Mullein (Verbascum thapsus) has been used for centuries across cultures for bronchitis, asthma, and respiratory ailments, specifically recognized by Eclectic physicians for irritable chronic bronchitis. The EBSCO evidence database lists it among proposed bronchitis treatments. Its mucilaginous leaves soothe inflamed bronchial membranes and saponins loosen mucus.
mustardTraditional
Mustard plasters applied to the chest have been used since at least the 19th century for bronchitis, and 'Mustard Poultices in the Treatment of Acute Bronchitis' was the subject of a published medical journal article as early as 1914. AITC vapors from the plaster are theorized to loosen mucus and improve airway circulation. No modern controlled clinical trials exist.
myrrhTraditional
Myrrh is documented in Western and Ayurvedic herbal traditions as a treatment for bronchitis, used as an expectorant and chest rub. Chest rubs made from diluted myrrh essential oil are specifically described for bronchitis with thick phlegm. An expectorant action is classified in formal herbal monographs.
nut grassTraditional
C. rotundus is listed in Ayurvedic pharmacopeias as a treatment for bronchitis. The antispasmodic and anti-inflammatory properties are mechanistically consistent with bronchial relief. Traditional use across Ayurvedic and Unani systems for respiratory conditions including bronchitis is documented.
onionTraditional
Traditional use of onion for bronchitis and its associated cough is documented across multiple traditional medicine systems, explicitly cited in peer-reviewed pharmacological reviews. Onion's antibacterial, bronchodilatory, and anti-inflammatory properties provide mechanistic support for this traditional indication.
ophiopogonTraditional
Ophiopogon japonicus has a well-documented history in TCM and encyclopedia sources for treating bronchitis and related chronic respiratory conditions. It is listed as an ingredient in multi-herb clinical formulas for chronic bronchitis with some clinical support at the formula level.
ophiopogon rootTraditional
Chronic bronchitis is a documented traditional indication for ophiopogon root across multiple classical Chinese and Japanese medicine sources. The herb's lung-moistening and antitussive properties are applied to the dry cough and airway inflammation of bronchitis in yin deficiency patterns. No isolated human clinical trials for bronchitis specifically exist.
orangeTraditional
Bronchitis is a documented traditional indication for Citrus sinensis, with orange peel used historically in Chinese, Ayurvedic, and European herbal medicine for bronchial inflammation, phlegm clearance, and cough. Clinical evidence specific to orange for bronchitis is absent.
oreganoTraditional
Bronchitis is one of the most historically consistent traditional indications for oregano, documented from ancient Greek medicine through medieval European and Turkish traditions. Oregano was used as an expectorant and antimicrobial agent for bronchial infections. Scientific evidence is preclinical only, with no human RCTs for bronchitis outcomes.
oriental arborvitaeTraditional
Chronic bronchitis is explicitly listed in the Chinese Pharmacopoeia (2010) as one of the primary indications for P. orientalis leaves. Classical TCM texts from 934 AD document this use. Anti-inflammatory and expectorant pharmacological activities provide mechanistic support.
partheniumTraditional
Feverfew has documented traditional use for coughs, colds, and respiratory disorders including bronchitis across historical European herbalism. The PMC systematic review and NCCIH both list respiratory disorders as traditional indications. No clinical trials exist for this specific use.
peachTraditional
Peach leaves (expectorant, demulcent) and seeds (antitussive) are documented in traditional medicine for bronchitis and chest congestion. The Eclectic tradition, TCM, and multiple botanical references cite this use. No clinical trials exist.
peppermintTraditional
Peppermint (Mentha × piperita) essential oil is listed in the EBSCO evidence database as a proposed treatment for bronchitis and cough, particularly via inhalation/steam. German Commission E approves peppermint oil for catarrh of the upper respiratory tract. Menthol acts as a TRPM8 receptor agonist reducing cough reflex sensitivity and has mild decongestant and bronchospasmolytic properties.
pineappleTraditional
Bromelain has been included in traditional formulas for bronchitis due to its mucolytic, anti-inflammatory, and immunomodulatory properties. Some clinical data support improvement of recovery from respiratory infections when bromelain is combined with antibiotics, but bronchitis-specific RCTs are lacking.
pistacia integerrima gallTraditional
Pistacia integerrima galls are specifically documented in traditional Ayurvedic and Unani medicine for chronic bronchitis, described as expectorant and antitussive. Multiple published ethnopharmacological reviews and a 2014 PubMed paper confirm this traditional indication. Preclinical bronchodilatory and anti-inflammatory data provide supporting mechanistic evidence.
platycodonTraditional
Platycodon grandiflorus (balloon flower root, Jie Geng) is a foundational herb in Traditional Chinese Medicine and Korean medicine for bronchial congestion, cough, and bronchitis, classified as an expectorant in the Chinese and Korean Pharmacopoeias. The 2025 Frontiers in Pharmacology systematic review on chronic bronchitis identifies its polysaccharides and platycodin D as suppressing mucin expression in CB models.
polygalaTraditional
P. tenuifolia is traditionally used in TCM and Kampo as an expectorant and antitussive for bronchitis. A 2024 preclinical study confirmed that PT liquid extract reduced cough, phlegm, and bronchial inflammation in a mouse bronchitis model via PI3K/AKT and MAPK pathways, providing mechanistic validation of traditional use. No human RCTs have been conducted.
polygala rootTraditional
Polygala root has documented traditional use and animal-model-validated effects for bronchitis. A 2024 PubMed-indexed study using validated bronchitis mouse models confirmed antitussive, expectorant, and anti-inflammatory activity of the liquid extract.
pterocarpus marsupiumTraditional
P. marsupium heartwood has documented traditional use for bronchitis in Ayurveda. This is consistently cited in peer-reviewed ethnobotanical reviews and a PMC-indexed phytochemical study.
quillajaTraditional
Oral Quillaja bark preparations have been used in traditional South American medicine specifically for bronchitis and cough for centuries. The saponins are thought to act as expectorants. No controlled human clinical trials support efficacy for bronchitis.
radishTraditional
Radish is listed in traditional ethnobotanical and folk medicine sources, including RxList, as used for bronchitis and inflammation of the airways. TCM and Ayurveda use radish seed and root preparations to clear phlegm from the lungs and relieve cough. No clinical trials have evaluated this use.
red cloverTraditional
Bronchitis is a well-documented traditional indication for red clover flowers across European and Asian herbal medicine. Multiple monograph sources cite its use as an expectorant and anti-inflammatory remedy for bronchitis. No clinical trial evidence has been identified.
red rootTraditional
Chronic bronchitis is among the most consistently mentioned traditional indications for Ceanothus americanus, appearing in Native American records, Eclectic materia medica, and contemporary herbalism. The expectorant and antispasmodic actions of the root are cited as the mechanism. No human clinical trials have assessed this use.
skullcapTraditional
S. baicalensis is traditionally used in TCM for respiratory infections with cough and thick phlegm, conditions overlapping with bronchitis. Ben Cao Gang Mu documents use for upper respiratory infections and pneumonia. Baicalin's anti-inflammatory and antimicrobial properties are pharmacologically relevant to bronchitic inflammation.
slippery elmTraditional
Slippery elm (Ulmus rubra) bark is listed among proposed bronchitis treatments in the EBSCO Research Starters evidence database. It is listed in the United States Pharmacopeia as an emollient and demulcent. Its high mucilage content coats and soothes irritated bronchial mucous membranes and reduces cough reflex irritation.
slippery elm barkTraditional
Slippery elm bark is the primary medicinal part of Ulmus rubra, listed in the EBSCO Research Starters evidence database among proposed bronchitis treatments. It is listed in the US Pharmacopeia as an emollient and demulcent for irritated mucous membranes. Its mucilaginous properties soothe bronchial mucous membranes and reduce cough irritation.
solomon's sealTraditional
Bronchitis is documented as a traditional indication for Solomon's seal as a demulcent and expectorant herb, particularly in Ayurvedic and Western herbal traditions. The herb soothes bronchial mucosa and facilitates mucus clearance from airways.
sphaeranthus indicusTraditional
S. indicus is traditionally used for cough and chest conditions in Ayurveda and Siddha, encompassing bronchitis-type presentations. Preclinical bronchodilatory and antitussive activities provide mechanistic support.
spruceTraditional
Spruce essential oil is traditionally used in aromatherapy and folk herbal medicine for bronchitis, leveraging its mucolytic (camphene) and anti-inflammatory (bornyl acetate) terpene constituents. Inner bark infusions were used for bronchial inflammation by Indigenous peoples. European herbal traditions record spruce preparations for bronchial catarrh.
stillingiaTraditional
Stillingia root has a well-documented traditional use for bronchitis, recognized by Native American healers and later by 19th-century Eclectic physicians who employed it as an expectorant and respiratory stimulant. It was used to loosen congestion and ease chronic bronchial inflammation. No clinical trials have been conducted to confirm efficacy.
sunflowerTraditional
Traditional herbal medicine consistently records sunflower seeds, leaves, and flowers as treatments for bronchitis and respiratory infections. Leaf syrups and decoctions were used to clear bronchial phlegm. Historical monographs list bronchitis among the primary indications for sunflower seed preparations.
sweet flagTraditional
A. calamus is traditionally used in bronchitis across Ayurveda, Chinese medicine, and multiple folk traditions, attributed to its expectorant, antispasmodic, and anti-inflammatory properties. Bronchodilatory activity is confirmed preclinically. Traditional classification as an expectorant appears consistently across pharmacopeial references.
tartarian asterTraditional
Tartarian aster root (Zi Wan) has been used in TCM for over 2,000 years specifically for bronchitis and cough with phlegm. Classical formulas such as Zhi Sou San, dating to around 1700 AD, incorporate it as a key ingredient for lung infections with coughing. Preclinical pharmacology confirms expectorant, antitussive, and antibacterial actions. No controlled human trials isolating its effect on bronchitis have been published.
trichosanthesTraditional
Trichosanthes is used in TCM for bronchitis and related respiratory conditions involving productive cough and phlegm-heat. It is listed as an expectorant in both Chinese and Korean classical medicine and is attributed to the lung meridian. The fruit and peel are indicated specifically for respiratory phlegm-heat patterns overlapping with bronchitis symptoms. Evidence is traditional and pharmacopoeial.
turmericTraditional
Turmeric (Curcuma longa) has traditional use in Ayurveda and TCM for bronchitis and respiratory inflammation, supported by published anti-inflammatory evidence in bronchial tissue and inclusion in a 2026 Nutrients review of plants for RTIs. Medical News Today (2024, peer-reviewed) notes curcumin's anti-inflammatory properties but limited direct clinical trial evidence specifically for bronchitis.
tylophoraTraditional
Tylophora leaves have been used in Ayurvedic and folk medicine across India, Sri Lanka, and Bangladesh for bronchitis, alongside asthma and whooping cough. The plant is documented in the Indian Ayurvedic system of medicines as a remedy for bronchitis. While the anti-asthmatic clinical evidence indirectly supports bronchial use, no clinical trials have specifically targeted bronchitis as a standalone diagnosis.
vasicinolTraditional
Vasicinol is a quinazoline alkaloid component of Adhatoda vasica (Malabar nut), documented in the plant's alkaloid profile alongside vasicine and vasicinone. It is present in Vasaka preparations listed in the Indian Pharmacopoeia for bronchitis and respiratory use, contributing to the overall pharmacological activity of the traditional Ayurvedic and Unani bronchitis remedy.
watercressTraditional
Watercress has been used since the time of Hippocrates as a stimulant and expectorant in the treatment of coughs and bronchitis. Its traditional use for bronchitis is documented across European, Middle Eastern, and North African medical traditions. In Germany, watercress is approved for phytotherapy use. No clinical RCT specifically for bronchitis has been conducted.
white oakTraditional
White oak bark tea is traditionally used for bronchitis, where its tannins and expectorant constituents are thought to help clear mucus and reduce inflammation of the bronchial passages. This use is documented across multiple traditional herbal systems. No clinical trials have been conducted.
wood betonyTraditional
Bronchitis is listed among the traditional uses of wood betony in European and folk herbal medicine, alongside other respiratory tract conditions, justified by its expectorant and anti-inflammatory properties. No clinical evidence exists.
xanthium (cockleburs)Traditional
Chronic bronchitis is listed among the traditional TCM indications for X. strumarium in the J Ethnopharmacol 2016 study documenting its ethnopharmacological relevance. Xanthatin has shown anti-inflammatory effects in asthmatic mouse models. Traditional antitussive use is documented across multiple sources.